SARS-CoV-2 ORF7a anticorps (AA 16-111)

N° du produit ABIN7469591

Détail du produit anti-SARS-CoV-2 ORF7a anticorps

Antigène: SARS-CoV-2 ORF7a

Épitope: AA 16-111

Reactivité: SARS Coronavirus (SARS-CoV)

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp SARS-CoV-2 ORF7a est non-conjugé

Application: Western Blotting (WB), Immunocytochemistry (ICC), Immunofluorescence (IF)

Réactivité croisée: SARS Coronavirus (SARS-CoV), SARS Coronavirus-2 (SARS-CoV-2)

Purification: Affinity purified by Protein G.

Immunogène: The immunogen used to generate this antibody corresponds to SARS-CoV ORF7a protein (16-111 a.a.).

Clone: 3C9

Isotype: IgG1

Information d'application

Indications d'application: WB: 1:500-1:3000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.

Commentaires:

Positive Control: ORF7a-transfected 293T cell

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: PBS, No Preservative

Agent conservateur: Without preservative

Stock: 4 °C,-20 °C

Stockage commentaire: Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.

Détails sur SARS-CoV-2 ORF7a

Antigène: SARS-CoV-2 ORF7a

Abstract: SARS-CoV-2 ORF7a Produits

Synonymes: anticorps ORF7a protein, anticorps ORF7a

Sujet: 2019-nCoV ORF7a , SARS-coV-2 ORF7a , COVID-19 ORF7a